Cardiac Rhythm Management (CRM) Devices Market to cross USD 13.7 Bn by 2025: Global Market Insights, Inc.

Major cardiac rhythm management devices market players include BIOTRONIK, ZOLL Medical, Boston Scientific, SCHILLER, Koninklijke Philips N.V., ABIOMED, Medtronic, and Abbott.

Selbyville, Delaware, Oct. 02, 2019 (GLOBE NEWSWIRE) --

Global cardiac rhythm management devices market revenue is poised to surpass a valuation of $13.7 billion by the end of 2025, according to a 2019 Global Market Insights, Inc. report. Growing population with risk of sudden cardiac arrest and the recent technological advancements such as implanted cardioverter defibrillator over traditional pacemakers are one of the few factors that are boosting the market growth positively.

Rising demand for implantable cardioverter defibrillator devices in developing economies such as Asia Pacific, Latin America and Middle East is owing to increased prevalence of cardiovascular disorders. Several training workshops for surgeons and patients regarding the implantable cardioverter defibrillator devices are planned by various manufacturers that has further led to rise in the awareness amongst patients and surgeons. Hence, aforementioned factors are estimated to spur the cardiac rhythm management devices market demand in the near future.

Request for a sample of this research report @

Pacemakers segment is expected to witness a CAGR of 2.9% over the forecast period. The cardiac rhythm management devices market growth is attributed to various factors such as increasing prevalence of heart attacks, growing geriatric population, technological advancements and sedentary lifestyle across the globe. According to a recent news article, around 63% of deaths across the globe are due to lifestyle disorders, owing to which young population are affected with cardiac arrhythmia. Hence, the adoption of CRM devices will witness significant growth in the coming years.

Germany cardiac rhythm management (CRM) devices market was valued at USD 974.1 million in 2018 and is projected to grow at lucrative rate over the forthcoming years. With rise in the prevalence of heart diseases, Germany ranked 8th for higher rates of heart-related deaths among the Organization for Economic Co-operation (OECD) countries.

Make an Inquiry for purchasing this report @

According to the Max Plank Institute for Biology and Aging, over 310 people per 100,000 die in Germany each year owing to cardiovascular diseases. Furthermore, growing number of cardiac resynchronization therapy devices implanted in the country is one of the significant factors that is propelling the market growth positively. In addition, according to the European Society of Cardiology, in 2014, the number of cardiac resynchronization therapy devices implanted in the country were around 19,000. Hence, increase in number of CRM device implantations across the country will enhance the business growth in the future.

Some of the major players in the global cardiac rhythm management devices market are BIOTRONIK, ZOLL Medical, Boston Scientific, SCHILLER, Koninklijke Philips N.V., ABIOMED, Medtronic, Abbott, among other players. Key players are adopting various strategic initiatives such as partnerships, collaborations, merger & acquisition in order to expand their geographic presence and product portfolio.

Browse key industry insights spread across 500 pages with 910 market data tables & 7 figures & charts from the report, “Cardiac Rhythm Management Devices Market By Product (Pacemakers {Implantable Pacemakers, External Pacemakers}, Defibrillators (Implantable Cardioverter Defibrillator [ICDs], {Subcutaneous Implantable Cardioverter Defibrillator, Transvenous Implantable Cardioverter Defibrillator {Single-chamber ICDs, Dual-chamber ICDs}, External Defibrillator [ED] {Manual ED, Automated ED {Semi-automated External Defibrillator, Fully Automated External Defibrillator} Wearable Cardioverter Defibrillator, Cardiac Resynchronization Therapy Devices [CRTs] {CRT-D, CRT-P}, Industry Analysis Report, Regional Outlook, Application Potential, Competitive Market Share & Forecast 2025 ” in detail along with the table of contents:

Table of Contents (ToC) of the report:

Chapter 3.  Cardiac Rhythm Management Devices Industry Insights

3.1. Industry segmentation

3.2. Industry landscape, 2014 – 2025 (USD Million and Units)

3.3. Industry impact forces

3.3.1.  Growth drivers  Growing prevalence of heart failure and other cardiac disorders  Technological advancements and introduction of innovative devices for cardiac rhythm monitoring  Rising sedentary lifestyle  Growing geriatric population base coupled with rising prevalence of obesity

3.3.2. Industry pitfalls & challenges  High cost of devices  Stringent regulatory approvals

3.4. Growth potential analysis

3.4.1.  By product

3.5. Regulatory landscape

3.6. Technology landscape

3.7. Porter’s analysis

3.8. Competitive landscape, 2018

3.8.1.  Strategy dashboard

3.9. PESTEL analysis

Browse Complete Table of Contents (ToC) @

Browse Related Report:

Cardiac Arrhythmia Monitoring Devices Market 2019-2025: Few of the prominent players operating in the global cardiac arrhythmia monitoring devices market are Biotronik, BioTelemetry, Inc., Medtronic plc, iRhythm Technologies, Inc., Nihon Kohden Corporation, St. Jude (Abbott Laboratories) among the other players. Sweden cardiac arrhythmia monitoring devices market is estimated to expand at 8% CAGR during the analysis period. Robust growth can be attributed to high pervasiveness of atrial fibrillation in Sweden as compared to other European countries.

Read more at:

About Global Market Insights

Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.


Contact Data